BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23362867)

  • 1. Evidence for a regulatory loop between IFN-γ and IL-33 in skin inflammation.
    Seltmann J; Werfel T; Wittmann M
    Exp Dermatol; 2013 Feb; 22(2):102-7. PubMed ID: 23362867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
    Albanesi C; Cavani A; Girolomoni G
    J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of interleukin 31 in human primary keratinocytes.
    Kasraie S; Niebuhr M; Baumert K; Werfel T
    Allergy; 2011 Jul; 66(7):845-52. PubMed ID: 21261663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis.
    Villagomez MT; Bae SJ; Ogawa I; Takenaka M; Katayama I
    Br J Dermatol; 2004 May; 150(5):910-6. PubMed ID: 15149503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis.
    Pastore S; Corinti S; La Placa M; Didona B; Girolomoni G
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):538-44. PubMed ID: 9564808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
    Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
    J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin.
    Szegedi K; Kremer AE; Kezic S; Teunissen MB; Bos JD; Luiten RM; Res PC; Middelkamp-Hup MA
    Exp Dermatol; 2012 Jun; 21(6):431-6. PubMed ID: 22621183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
    Antúnez C; Torres MJ; Mayorga C; Corzo JL; Jurado A; Santamaría-Babi LF; Vera A; Blanca M
    Pediatr Allergy Immunol; 2006 May; 17(3):166-74. PubMed ID: 16672002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis.
    Rebane A; Zimmermann M; Aab A; Baurecht H; Koreck A; Karelson M; Abram K; Metsalu T; Pihlap M; Meyer N; Fölster-Holst R; Nagy N; Kemeny L; Kingo K; Vilo J; Illig T; Akdis M; Franke A; Novak N; Weidinger S; Akdis CA
    J Allergy Clin Immunol; 2012 May; 129(5):1297-306. PubMed ID: 22445417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation.
    Igawa K; Satoh T; Hirashima M; Yokozeki H
    Allergy; 2006 Dec; 61(12):1385-91. PubMed ID: 17073866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors.
    Savinko T; Matikainen S; Saarialho-Kere U; Lehto M; Wang G; Lehtimäki S; Karisola P; Reunala T; Wolff H; Lauerma A; Alenius H
    J Invest Dermatol; 2012 May; 132(5):1392-400. PubMed ID: 22277940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis.
    El-Mezayen RE; Matsumoto T
    Clin Immunol; 2004 Apr; 111(1):61-8. PubMed ID: 15093553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 33 is induced by tumor necrosis factor alpha and interferon gamma in keratinocytes and contributes to allergic contact dermatitis.
    Taniguchi K; Yamamoto S; Hitomi E; Inada Y; Suyama Y; Sugioka T; Hamasaki Y
    J Investig Allergol Clin Immunol; 2013; 23(6):428-34. PubMed ID: 24459820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
    Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
    J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitis.
    Purwar R; Werfel T; Wittmann M
    J Invest Dermatol; 2006 May; 126(5):1043-51. PubMed ID: 16484990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis.
    Meyer N; Zimmermann M; Bürgler S; Bassin C; Woehrl S; Moritz K; Rhyner C; Indermitte P; Schmid-Grendelmeier P; Akdis M; Menz G; Akdis CA
    J Allergy Clin Immunol; 2010 Apr; 125(4):858-865.e10. PubMed ID: 20227751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
    Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
    J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer T cells expressing IFN-gamma and IL-4 in lesional skin of atopic eczema.
    Simon D; Kozlowski E; Simon H
    Allergy; 2009 Nov; 64(11):1681-4. PubMed ID: 19735490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases.
    Wittmann M; Purwar R; Hartmann C; Gutzmer R; Werfel T
    J Invest Dermatol; 2005 Jun; 124(6):1225-33. PubMed ID: 15955098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitis.
    Scarponi C; Nardelli B; Lafleur DW; Moore PA; Madonna S; De Pità O; Girolomoni G; Albanesi C
    J Interferon Cytokine Res; 2006 Mar; 26(3):133-40. PubMed ID: 16542135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.